Cancer Drugs Fund expected to release £140m to NHS

Since the new Cancer Drugs Fund (CDF) opened in July 2016, nearly 15,700 patients have benefited from the 52 drugs treating 81 different types of cancer.

The CDF, which is also expected to release at least £140million into the NHS over the next five years through discounts on eight treatments, also enabled patients to benefit from new cancer drugs at least four months earlier than was previously the case.

John Stewart, director of Specialised Commissioning at NHS England, said: “Thousands of cancer patients are benefitting from earlier access to innovative treatments through the new Cancer Drugs Fund. Alongside the new look process, tough negotiations and flexibility are leading to more deals with pharmaceutical companies achieving real value for money for the NHS, meaning the new Fund is not only benefiting patients, but industry, the NHS and the taxpayer too.”

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho